Thinking about trading options or stock in Moderna, Exxon Mobil, American Airlines, Blink Charging, or Ambarella?

PR Newswire

NEW YORK, Dec. 4, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for MRNA, XOM, AAL, BLNK, and AMBA.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-moderna-exxon-mobil-american-airlines-blink-charging-or-ambarella-301186543.html

SOURCE InvestorsObserver

Thinking about buying stock in Spirit Airlines, Infinity Pharmaceuticals, Johnson & Johnson, BP, or Carnival Corp?

PR Newswire

NEW YORK, Dec. 4, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for SAVE, INFI, JNJ, BP, and CCL.

To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver’s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock’s overall suitability for investment.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-spirit-airlines-infinity-pharmaceuticals-johnson–johnson-bp-or-carnival-corp-301186539.html

SOURCE InvestorsObserver

Thinking about trading options or stock in Norwegian Cruise Line, Pfizer, General Electric, Walt Disney, or Intel Corp?

PR Newswire

NEW YORK, Dec. 4, 2020 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for NCLH, PFE, GE, DIS, and INTC.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-norwegian-cruise-line-pfizer-general-electric-walt-disney-or-intel-corp-301186533.html

SOURCE InvestorsObserver

Daiki Axis Co., Ltd. (4245, Tokyo) Overview of Operating Performance for the Nine Months Ended September 30, 2020

In the nine months ended September 30, 2020, operating income and ordinary income increased. The renewable energy segment grew substantially, becoming a stable source of earnings.

PR Newswire

TOKYO, Dec. 4, 2020 /PRNewswire/ —

Summary of Results

The business environment surrounding the Company deteriorated during the nine months ended September 30, 2020 due to the rapid global spread of the novel coronavirus pandemic (COVID-19). Meanwhile, the industry was also impacted by the spread of COVID-19 as restrictions on sales activities resulted in order booking delays.

Under these circumstances, the Company is promoting a strategy focused on improving future profitability. In the environmental equipment segment, the Company pursued overseas business development and strengthened sales in the recurring-revenue energy service company (ESCO) business in the areas of maintenance and water. At the same time, in the household equipment-related business segment, the Company engaged in efforts aimed at transitioning from stability in business to growth, including the launch of an e-commerce business. Additionally, in the renewable energy segment, the Company conducted initiatives targeting the achievement of a recycling-oriented society and enhanced stable income-generating capabilities.

Net sales in the nine months ended September 30, 2020 were JPY25,687 million (down 3.4% YoY). However, thanks to measures to improve comprehensive income, gross profit came to JPY5,430 million (up 6.2% YoY) while operating income closed at JPY830 million (up 9.9% YoY) and ordinary income was JPY961 million (up 12.3% YoY). In terms of extraordinary gains and losses, the Company recorded a gain of JPY152 million on sales of subsidiaries and a JPY236 million impairment loss. The Company has been recording an annual preferred dividend of 4.8% paid to holders of classified stock in consolidated subsidiary Sylphid Inc. since the third quarter of the fiscal year ended March 31, 2019, which had an impact on profit attributable to non-controlling interests. Consequently, profit attributable to owners of parent amounted to JPY335 million (down 21.2% YoY) in the nine months ended September 30, 2020.

In the environmental equipment segment, sales of wastewater treatment systems were down year on year. The Company recorded a measurable amount of domestic sales from large-scale projects in the nine months ended September 30, 2019. However, sales in the nine months ended September 30, 2020 did not measure up to this amount, and overseas sales were affected substantially by a deteriorating business climate caused by the COVID-19 pandemic. Sales in the recurring-revenue energy service company (ESCO) business in the area of maintenance were strong but remained level year on year in the recurring-revenue ESCO business in the area of water despite an increase in contracts due primarily to a decrease in customer water usage. Consequently, sales in the environmental equipment segment were JPY12,743 million (down 8.6% YoY) while operating income was JPY798 million (up 15.0% YoY).

In the household equipment-related business segment, construction-related sales were impacted by product shipment delays that arose because many suppliers associated with these sales have component production sites in China, but the Company was able to deal with this impact by substituting alternative products. Sales were also strong when compared to the nine months ended September 30, 2019 due to replacement demand for store equipment and other facilities. In terms of residential machinery construction, the Company was involved in a large-scale new store construction project, but medium- to large-scale projects were scarce overall. Despite this project scarcity, the Company benefitted from sales generated by Fujiwara Reiki, which became a consolidated subsidiary in October 2019, and overall residential machinery construction sales were strong compared to the nine months ended September 30, 2019. Sales of retail products through DIY stores were impacted by lower sales to existing stores, and sales activities in the EC business, including field surveys targeting end users, were delayed due to the spread of the novel coronavirus pandemic. As a result, sales in the household equipment-related business segment were JPY11,109 million (up 4.5% YoY), and operating income was JPY299 million (down 7.3% YoY).

In the renewable energy segment, through its solar power sales business, the Company has been renting roof space on DCM Group stores since FY2018. Within this space, it has constructed power generation facilities and sold electricity under a feed-in tariff (FIT) system. In the nine months ended September 30, 2020, the Company began selling electricity from six more facilities, and sales increased substantially year on year as a result. According to the Company’s plans, only two facilities that have not yet begun selling electricity remain. Meanwhile, sales declined year on year both the biodiesel fuel and compact wind generation businesses. Consequently, sales in the renewable energy segment were JPY690 million (up 34.3% YoY), and operating income was JPY282 million (up 39.7% YoY).

In other segments, sales in the engineering business fell substantially year on year due to the sale of DAD Co., Ltd. at the end of the six-month period ended June 30, 2020. In the household drinking water business, sales were strong compared to the nine months ended September 30, 2019. As a result, sales in other segments were JPY1,143 million (down 23.8% YoY) and operating income was JPY144 million (up 10.9% YoY).

In terms of financial status, the Company’s liquid assets, non-current assets, and current liabilities declined due to the transfer of all shares in DAD Co., Ltd. at the end of the six-month period ended June 30, 2020. Meanwhile, noncurrent liabilities increased as the Company issued green bonds (unsecured bonds available only to qualified institutional investors) with the goal of conducting capital investment in the business of selling power from solar power facilities and the compact wind generation business.

The Company has released its consolidated results forecast for the fiscal year ending December 31, 2020. The forecast projects net sales of JPY34,400 million (down 3.8% YoY), operating income of JPY1,010 million (up 0.9% YoY), ordinary income of JPY1,160 million (up 0.4% YoY), profit attributable to owners of parent of JPY550 million (down 29.7% YoY), and EPS of JPY44.32.

Daiki Axis Co., Ltd. (4245, First Section, TSE http://www.daiki-axis.com/english/)
“Summary of Consolidated Financial Results for the Nine Months Ended September 30, 2020” is available here:
http://www.daiki-axis.com/ir/info/index09.html

Release Disclaimer
This release is for the purpose of providing information to serve as a reference for investment decisions and not for the purpose of soliciting investment. Please exercise your own judgment on final decisions such as investment policy, timing and selection. Please be advised that we do not assume any responsibility for damages caused by this service.

Release Inquiries
Borderless IR Co., Ltd. http://b-ir.co.jp/english/main.php
Sixth Floor, Toyo Building 1-2-10 Nihonbashi, Chuo-ku, Tokyo 103-0027 JAPAN
TEL: +81-3-4588-6706 POC: Toru Fukuda
Contact form: http://b-ir.co.jp/english/contact.php

Borderless IR specializes in the global distribution of IR content, including the dissemination of newsletters and annual reports providing the latest information and main strengths of Japanese companies directly to overseas investors through leading global media, corporate information database services and mailing lists. Borderless is also engaged in supporting other global IR efforts.

©Borderless IR Co., Ltd. All rights Reserved

The content of this release may not be duplicated or reproduced.

 

Cision View original content:http://www.prnewswire.com/news-releases/daiki-axis-co-ltd-4245-tokyo-overview-of-operating-performance-for-the-nine-months-ended-september-30-2020-301186389.html

SOURCE Daiki Axis Co., Ltd.

Sabine Royalty Trust Announces Monthly Cash Distribution For December 2020

PR Newswire

DALLAS, Dec. 4, 2020 /PRNewswire/ — Simmons Bank, as Trustee of the Sabine Royalty Trust (NYSE: SBR), today declared a cash distribution to the holders of its units of beneficial interest of $0.124040 per unit, payable on December 29, 2020, to unit holders of record on December 15, 2020.  Sabine’s cash distribution history, current and prior year financial reports and tax information booklets, a link to filings made with the Securities and Exchange Commission and more can be found on its website at http://www.sbr-sabine.com/.  Additionally, printed reports can be requested and are mailed free of charge.

During the month of November, the respective shelter-at-home/work-from-home orders across the spectrum of the industry has significantly affected the posting of revenues for the Trust, until the following month of November.  As adjustments are made accordingly, the functions of the Trust are still being performed, although on a delayed basis.  We will continue to strive to make the operations of the Trust and its providers, as fluid as possible.

Also, the impact of the precipitous drop in energy pricing are not reflected in this month’s revenue, however it has been seen in the previous months.  With the assets of the Royalty Trust being almost true royalty interest ownership of established production streams, production should continue, however the over-supply of existing industry inventories will affect the ability to transport on down the production stream. As the result of these aforementioned factors, various producers/operators/purchasers may not be able to continue as they have been and could affect payment to the Trust.  We are taking steps to monitor those various entities as they have a direct relationship with the Trust.  The ownership of the Trust’s various royalty interests should not be diminished, as that will continue.

This distribution reflects primarily the oil production for September 2020 and the gas production for August 2020.  Preliminary production volumes are approximately 49,182 barrels of oil and 761,607 Mcf of gas.  Preliminary prices are approximately $38.40 per barrel of oil and $1.68 per Mcf of gas.

The table below compares this month’s production and prices to the previous month’s:

Net to Trust Sales

Volumes

Average Price

Oil
(bbls)

Gas
(Mcf)

Oil

(per bbl)

Gas

(per Mcf)

Current Month

49,182

761,607

$38.40

$1.68

Prior Month

54,132

619,545

$37.23

$1.45

Revenues are only distributed after they are received, verified and posted.  Most energy companies normally issue payment of royalties on or about the 25th of every month, and depending on mail delivery, a varying amount of royalties are not received until after the revenue posting on the last business day of the month.  The revenues received after that date will be posted within 30 days of receipt.

Due to the timing of the end of the month of November, approximately $671,000 of revenue received will be posted in the following month of December in addition to normal receipts during December.  Since the close of business in November and prior to this press release, there has been approximately $555,000 in revenue received.

Approximately $722,000 for 2020 Ad Valorem taxes was deducted from this month’s distribution as compared to $922,000 this time last year.  These payments are normal expenditures at this time of year.

The 2020 tax information packets are expected to begin mailing directly to unitholders in early March 2021.  A copy of Sabine’s 2020 tax information booklet will be posted on Sabine’s website by March 1, 2021.  In addition to the tax booklet the Sabine website will also offer two simple calculators for computing the income and expense amounts and the cost depletion.  The calculators are currently expected to be updated with the 2020 tax information by February 26, 2021.

The 2019 Annual Report with Form 10-K and the January 1, 2020 Reserve Summary is available on the Sabine website at http://www.sbr-sabine.com/. 

Cision View original content:http://www.prnewswire.com/news-releases/sabine-royalty-trust-announces-monthly-cash-distribution-for-december-2020-301186555.html

SOURCE Sabine Royalty Trust

Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare

Skin Oncology Firm MedC Biopharma Launches Private Placement Offering on DealSquare

Clinical-stage company is focused on innovation in skin health worldwide

TORONTO–(BUSINESS WIRE)–MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, has announced the launch of its $3 million private placement offering using the DealSquare platform, powered by NEO and DealMaker technology.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201204005071/en/

MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)

MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)

A clinical-stage biopharmaceutical company, MedC ($MEDCB) develops and commercializes cannabinoid and other natural compound-containing products for use in the consumer, veterinary, medical skin, and general health markets. The company has already developed two drugs toward clinical trials for CTCL – Skin (Cutaneous) T-cell Lymphoma and Cutaneous Leishmaniasis, both of which are recognized as orphan conditions with unmet needs, and as markets with huge potential. MedC is developing its own proprietary red sea-algae “Algel” gel-based products, with a variety of applicable uses for skin health and wellness, and is also pursuing opportunities in veterinary medication and pet health, specifically oncology and inflammation-related indications (an estimated $400 million annual market).

MedC’s campaign marks the first capital raise through the joint service offering between DealSquare and DealMaker. DealSquare, powered by NEO, is a fully automated and centralized platform allowing capital raisers to publish their private placement opportunities, dealers to complete their due diligence, and advisors and investors to electronically subscribe to a deal. DealMaker provides the back-office technology, transaction engine, and electronic signature functionality for investors submitting orders electronically, compliantly, globally. Together, DealSquare, NEO, and DealMaker provide MedC with the smoothest transaction experience and broadest reach of capital market participants.

“The launch of our private offering leveraging the joint service capabilities of these reputable platforms marks a significant step towards MedC taking its place amongst industry leaders that are determined to legitimize and deliver the health benefits of cannabinoids to the global community,” remarked Dr. Owen Van Cauwenberghe, President of MedC. “Our tireless efforts and commitment to substantiated medical and health claims for these products will ensure that their benefits will be available to all those in need. We are fortunate to be able to take advantage of the combined DealSquare, NEO, and DealMaker offering.”

MedC’s listing on DealSquare, combined with the technology of DealMaker, creates an opportunity for investors who believe there is a global need to mature and legitimize the cannabis and cannabis-related health and medical market, by supporting the development of products that deliver health and wellness benefits. With the funds raised from the campaign, MedC is targeting international expansion, initially across Canada and Australia, with plans to launch in Europe, UK, Asia, and Latin America shortly thereafter. It will also expand its product offering with new lines for different markets and multiple dose formats. There will be a strong focus on research and development of high value market products, as well as regulatory work, thus enabling MedC to further enhance its product offering.

“We welcome MedC as our first partner in the joint initiative we have launched with DealMaker,” said Peter-Paul Van Hoeken, Managing Director of DealSquare. “The cannabis-related health and medical sector is a fast-growing market that offers attractive investment opportunities. The MedC listing enables dealers and advisors to offer this investment opportunity to their clients, and to execute investments efficiently and in a fully digitized way through our online platform.”

“MedC is well-positioned to deliver effective medical treatments for skin conditions in a highly underserviced market, and the funds raised from this joint campaign will help make that possible,” added Rebecca Kacaba, CEO of DealMaker. “We are honoured to be powering MedC in raising the capital needed to achieve rapid growth.”

“MedC’s capital raise is truly a noteworthy event,” concluded Jos Schmitt, President and CEO of NEO. “It marks the coming together of like-minded organizations, all of whom are on a relentless pursuit of innovation for the benefit of others. By harnessing the combined strength of DealMaker and DealSquare, powered by NEO, MedC gains exposure to a wider investor community, both here in Canada and abroad.”

To view MedC Biopharma’s private placement offering on DealSquare, click here. For direct investor investment, click here. The MedC Biopharma ticker is available under MEDCB on existing advisor order entry systems.

About MedC Biopharma

MedC Biopharma is a science-driven company focused on developing, producing, and delivering differentiated cannabinoid and other natural compound-containing products targeting the consumer, veterinary and medical skin & general health markets.

Connect with MedC Biopharma: Website | LinkedIn

About DealSquare

A joint initiative between NEO and Silver Maple Ventures, DealSquare, is Canada’s first centralized dealer platform for private placements, digitally connecting capital-raisers to investment dealers, their advisory networks, and their investors. With the complete roll-out of the platform in early 2020, DealSquare supports the entire private placement process: capital raisers publish their private placement opportunities; dealers complete their due diligence; and advisors electronically subscribe to a deal, with exempt securities seamlessly integrated into client accounts and back office systems utilizing NEO technology.

Connect with DealSquare: Website | LinkedIn | Twitter

About DealMaker

DealMaker is an innovative cloud-based platform for the capital raising and settlement of domestic and international private placements in capital markets, KYC and Fund Formation. DealMaker makes private placement transactions surprisingly pleasant, delivering speed, innovation, and efficiency to the global private capital markets. Financings using DealMaker close faster, with greater control over the process which creates a better experience. DealMaker strives for a simpler, cleaner way of doing things on one global platform.

Connect with DealMaker: Website | LinkedIn | Twitter

About NEO

NEO is a group of established fintech companies that provide capital markets infrastructure designed for and led by the industry. NEO’s competitive drive, innovation, and advocacy enable change for the better. The NEO Exchange is a progressive stock exchange that brings together investors and capital raisers within a fair, efficient, and service-oriented environment; and DealSquare, powered by NEO technology, is a platform that enables the distribution of financial assets not listed on a stock exchange in a way that reduces costs, minimizes operational risks, and improves the investor experience.

Connect with NEO: Website | Twitter| LinkedIn

Media Contact:

DealSquare

John Hills

E: [email protected]

P: 289 962 1708

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Technology Research Clinical Trials Biotechnology Networks Health Data Management Other Science Science

MEDIA:

Logo
Logo
Photo
Photo
MedC Biopharma Corporation (“MedC”), a science-driven company that develops, produces and delivers innovative skin oncology medication worldwide, participates in a digital market open to celebrate its private placement offering on DealSquare. (Photo: Business Wire)

Investview (INVU) Reports Record $1.4 Million Month Bitcoin Mining Revenue and Increased Bitcoin Holdings

Eatontown, NJ, Dec. 04, 2020 (GLOBE NEWSWIRE) — via NewMediaWire –Investview, Inc. (OTCQB: INVU), a diversified financial technology and global distributor organization that operates through its subsidiaries to provide financial education tools, content, research and management of digital asset technology that mines cryptocurrencies, with a focus on Bitcoin mining and the generation of digital assets, has reached a new all-time-high monthly revenue and profit margin as INVU increased its Bitcoin mining revenue by an estimated 67% (from approximately $840 thousand in October 2020 to approximately $1.4 million in November 2020) and profit margin by an estimated 109% (from approximately $386 thousand in October 2020 to approximately $808 thousand) in November 2020. Investview produced nearly 80 Bitcoin in November- averaging approximately 2.64 BTC per day.  This growth was made possible through INVU’s strategic investments in cryptocurrency mining hardware, software & enhanced IT operations, and was further bolstered by significant Bitcoin price increases which appreciated by over 80% in the last 60 days to near $19,500.

Investview’s EVP of Crypto Operations Rob Walther commented, “We are pleased to announce that INVU’s strategic decisions to increase investment into additional mining hardware, optimize mining software, and enhance our IT operation, combined with the substantial increase in the price of Bitcoin, has contributed to the largest revenue and profit margin ever earned by INVU’s digital asset mining operation. This represents a new milestone for INVU with revenue growth of 67% to $1.4 million and profits expanding by over 109% to $808 thousand in November.   With favorable Bitcoin price projections ahead, INVU can expect to continue this aggressive growth trajectory through our additional & planned mining equipment purchases, and through our ongoing enhancements to IT operations.” 

About Investview, Inc.

Investview, Inc. is a diversified financial technology and global distributor organization that operates through its subsidiaries to provide financial education tools, content, research and management of digital asset technology that mines cryptocurrencies, with a focus on Bitcoin mining and the generation of digital assets.  For more information on Investview and its family of wholly-owned subsidiaries, please visit:www.investview.com

Forward-Looking Statements

All statements in this release that are not based on historical fact are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,”  “should,” “could,” “seek,” “intend,” “plan,” “goal,” “estimate,” “anticipate” or other comparable terms.  These forward-looking statements are based on Investview’s current beliefs and assumptions and information currently available to Investview and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. More information on potential factors that could affect Investview’s financial results is included from time to time in Investview’s public reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.  The forward-looking statements made in this release speak only as of the date of this release, and Investview, Inc. (“INVU”) assumes no obligation to update any such forward-looking statements to reflect actual results or changes in expectations, except as otherwise required by law.

Investor Relations

Contact: Mario Romano
Phone Number: 732.889.4308
Email: [email protected]



Coupa Software to Participate Virtually in the Barclays Global Technology, Media and Telecommunications Conference

PR Newswire

SAN MATEO, Calif., Dec. 4, 2020 /PRNewswire/ — Coupa Software (NASDAQ: COUP), announced today that its management team will participate virtually in the Barclays Global Technology, Media and Telecommunications Conference on Wednesday, December 9, 2020.

The management team’s live remarks, scheduled to begin at 8:30 am PT (11:30 am ET), can be accessed from Coupa’s investor relations website at http://investors.coupa.com. A replay of the live webcast will also be available on this website for at least 90 days following the event.

About Coupa Software

Coupa empowers companies around the world with the visibility and control they need to spend smarter and safer. To learn more about how Coupa can help you spend smarter, visit www.coupa.com. Read more on the Coupa Blog or follow @Coupa on Twitter.

 

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/coupa-software-to-participate-virtually-in-the-barclays-global-technology-media-and-telecommunications-conference-301186323.html

SOURCE Coupa Software

Virtual Expertise Software, Focus-Enhancing Headphones Named Best New Tech in ISG Startup Challenges

New technologies that improve pandemic work life chosen by audiences at virtual ISG events

STAMFORD, Conn., Dec. 04, 2020 (GLOBE NEWSWIRE) — Software that enables businesses to remotely and visually resolve user problems, and headphones with an EEG microchip to improve user focus, productivity and well-being, were voted the winners of ISG Startup Challenges at two recent events hosted by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.

Help Lightning was voted the winner of the ISG Startup Challenge at the ISG Digital Business Summit, November 17-18. After hearing entrepreneurs from three startups pitch their businesses to a panel of judges, audience members voted in a live poll for Help Lightning’s virtual expertise software, which service organizations and call centers use to visually collaborate remotely with colleagues or customers as if they are working side-by-side.

“As businesses and employees reimagine the way they work and leverage smart technologies that can help in real time, Help Lightning isn’t just a bandage on our pandemic circumstances, it’s an improvement,” said Shafqat Azim, partner, ISG Digital Strategy and Solutions and host of the event. “Service representatives dial into Help Lightning on an existing device or browser and show, not just tell, users how to resolve a problem. Even from a thousand miles away, this is a faster, easier way to improve customer satisfaction.”

Aces headphones were voted the ISG Startup Challenge winner at the virtual ISG Agile Enterprise Summit, October 6. By observing brain waves during tasks, Aces headphones evaluate how a user’s mind is functioning and leverage a developmental-learning approach to help users improve their ability to focus for sustained periods of time through continuous practice.

“Efficiency and peak performance are the goal of the agile enterprise. What better tool in our chaotic, turbulent times than a set of headphones that help users focus, thrive, feel at ease and learn to achieve their best productivity,” said Ola Chowning, partner, ISG Digital Strategy and Solutions and host of the ISG Agile Enterprise Summit. “In choosing Aces headphones, audience members recognized that business leaders cannot make important decisions quickly and effectively if they can’t think clearly. This is one of many innovations that will surely have a lasting impact beyond the pandemic.”

For more information about the ISG Startup Challenge, visit the ISG Events website.

About ISG

ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.

# # #



Will Thoretz
Information Services Group, Inc. 
+1 203 517 3119
[email protected]

Jim Baptiste
Matter Communications for ISG
+1 978 518 4527
[email protected]

Village Farms International’s Investee DutchCanGrow Provides Update on Production Licensing Lottery for Netherlands

PR Newswire

VANCOUVER, BC, Dec. 4, 2020 /PRNewswire/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) (TSX: VFF) today announced that DutchCanGrow Inc. (“DCG”), a Netherlands-based cannabis enterprise in which Village Farms holds just under a 16% ownership stake, as the outcome of a lottery process, did not receive one of the ten cannabis production licenses (the “License”) under the Dutch government’s 10-city Experiment to Investigate Closed Cannabis Supply Chains (know by its Dutch language acronym “WECG”).

Based on the results of the random draw, DCG has been placed in the eighth position on a waiting list for a License.  The applicants drawn in the one to ten positions to potentially receive of one the ten available licenses will be subject to a thorough review of their business affairs and personnel under the Public Administration (Probity Screening) Act (known by its Dutch language acronym “BIBOB”), which is expected to be completed in eight to 12 weeks.

“We are extremely proud that DCG was one of only 40 applicants out of a total of nearly 150 to even be considered for a production license, and await the outcome of the rigorous and extensive review of the initial ten applicants drawn in the lottery,” said Michael DeGiglio, CEO, Village Farms International. “Village Farms undertook this process with the understanding that the Licenses would be awarded based on merit, not a random draw. We believe we would be a significant contributor to the success of the WECG, providing safe, premium-quality, legally-grown cannabis in the Netherlands.”

Village Farms is one of six equal shareholders in DCG owning just under 16% each, with a seventh shareholder owning 5%. 

About Village Farms International, Inc.

Village Farms is one of the largest and longest-operating greenhouse growers in North America, and is leveraging its decades of experience in large-scale, low-cost intensive agriculture and as a vertically integrated produce supplier to pursue high-value, high-growth plant-based Consumer Packaged Goods opportunities in cannabis and CBD in North America and selected markets internationally.

In Canada, British-Columbia-based Pure Sunfarms is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer, one of the best-selling brands, and has generated profitability for seven consecutive quarters.

In the U.S., subject to compliance with all applicable U.S. federal and state laws, Village Farms is pursuing a strategy to become a leading developer and supplier of branded and white-labeled CBD products targeting “big box” and other major retailers and consumer packaged goods companies, and with one the largest greenhouse operations in country, is well positioned for the potential federal legalization of high-THC cannabis.

Internationally, Village Farms is strategically targeting selected, nascent, legal cannabis and CBD opportunities with significant long-term potential, with an initial focus on the Asia-Pacific region through its investment in Australia-based Altum International.

Cautionary Statement Regarding Forward-Looking Information

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is subject to the safe harbor created by those sections. This press release also contains “forward-looking information” within the meaning of applicable Canadian securities law. We refer to such forward-looking statements and forward-looking information collectively as “forward-looking statements”. Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “try”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this press release are subject to risks that may include, but are not limited to: our limited operating history, including that of Pure Sunfarms and our start-up operations of growing hemp in the United States; the legal status of Pure Sunfarms cannabis business; risks relating to obtaining additional financing, including our dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp and agricultural businesses; the ability of Pure Sunfarms to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and licenses (e.g., Pure Sunfarms’ ability to obtain licenses for its Delta 2 greenhouse facility as well as additional licenses under the Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts, S.C. 2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our regulatory requirements; risks relating to conversion of our greenhouses to cannabis production for Pure Sunfarms; risks related to rules and regulations at the U.S. federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing COVID-19 pandemic; and tax risks.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this press release. In particular, we caution you that our forward-looking statements are subject to the ongoing and developing circumstances related to the COVID-19 pandemic, which may have a material adverse effect on our business, operations and future financial results.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Cision View original content:http://www.prnewswire.com/news-releases/village-farms-internationals-investee-dutchcangrow-provides-update-on-production-licensing-lottery-for-netherlands-301186553.html

SOURCE Village Farms International, Inc.